Table 1 Clinicopathologic features of patients with positive vs. negative axillary US-FNA
Variables | Positive US-FNA [N(%)] | Negative US-FNA [N(%)] |
|---|---|---|
Average age | 52.53 ± 13.2 | 53 ± 11.1 |
Tumor type | ||
IDC | 39/65 (60) | 28/36 (77.8) |
IDC (residual) | 13/65 (20) | 0/36 (0) |
IDC-DCIS | 0/65 (0) | 1/36 (2.8) |
IDC/ILC | 0/65 (0) | 3/36 (8.3) |
ILC | 2/65 (3.1) | 2/36 (5.6) |
ILC (residual) | 1/65 (1.5) | 0/36 (0) |
DCIS | 1/65 (1.5) | 0/36 (0) |
DCIS (residual) | 1/65 (1.5) | 0/36 (0) |
Adenosquamous | 0/65 (0) | 1/36 (2.8) |
IMC with neuroendocrine features | 0/65 (0) | 1/36 (2.8) |
No residual | 6/65 (9.2) | 0/36 (0) |
No tumor | 1/65 (1.5) | 0/36 (0) |
NA | 1/65 (1.5) | 0/36 (0) |
Modified SBR grade | ||
(3/3) | 23/65 (35.4) | 19/36 (52.8) |
(2/3) | 23/65 (35.4) | 12/36 (33.3) |
(1/3) | 4/65 (6.2) | 3/36 (8.3) |
NA | 15/65 (23) | 2/36 (5.6) |
Size | Mean = 3.4 +/- 3.3 cm | Mean = 2.3 ± 1.5 cm |
Median = 2.5 cm | Median = 2.0 cm | |
Neoadjuvant therapy | ||
None | 43/65 (66.2) | 33/36 (91.7) |
Yes | 21/65 (32.3) | 3/36 (8.3) |
NA | 1/65 (1.5) | 0/36 (0) |